Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-30

Clinical Trial Update: The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Yiqilishui Formula for sepsis-induced myocardial dysfunction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiqilishui Formula

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Sepsis Induced Myocardial Dysfunction | Phase 2 | Status: RECRUITING